Investment

This week’s family/private investment office deals

Post-IPO Investment

Invus, a New York City-based investment business backed by Eric Wittouck, one of Belgium’s richest individuals, has invested in Cyclerion Therapeutics, a biotech group. Invus was one of seven investors committing $18 million to the Cambridge, Massachusetts-based group. 

Hunt Technology Ventures, a Dallas-based investment group owned by David Hunt, a descendant of H.L Hunt, at one point in the 1970s the richest individual alive, has invested in Maven, a digital publishing group. Hunt Technology was one of two investors committing $20 million to the Seattle-based group. 

Unspecified Rounds

Smedvig Capital, the London-based family investment group of the Norwegian Smedvig family, has invested in Antidote, a digital health company. Smedvig was one of four investors committing $23.2 million to the London-based group. 

Seed

Geneva-based Celeste Management, an investment office owned by a member of the Louis-Dreyfus family, has invested in Adionics, a lithium mining group. Celeste was one of three investors seeding the French group with €7 million. 

Koç Holding, Turkey’s biggest conglomerate in revenue terms and owned by the Koç family, has invested in Agumency, a technology company using augmented reality services. Koç Holding was one of two investors seeding the Turkish company with $1 million. 

Presight Capital, a New York City-based venture group/fund owned by German investor Christian Angermayer, has invested in Opontia, a Dubai-based e-commerce platform. Presight was one of seven investors committing an unspecified amount to the startup. 

Exor Seeds, owned by the Agnelli family, has invested in Norbert Health, a healthcare group. Exor was one of six investors seeding the New York-based startup with $5 million. 

Titan Capital, a private investment office set up by Snapdeal (an Indian e-commerce platform) founders Kunal Bahl and Rohit Bans, has invested in Fyllo, an IoT and AI-based agriculture service company. Titan was one of three investors committing INR30 million to the Indian startup. 

Series A 

Shamrock Holdings, the family office of the Disney family of Walt Disney fame, has invested in Etiometry, a provider of next-generation patient monitoring software and advanced analytics for hospital ICUs. Shamrock was one of two investors committing $9 million to the Boston-based group

Euclidean Capital, Jim Simons’ investment group, has invested in Stablix Therapeutics, a biotech group. Euclidean was one of five investors committing $63 million to the New York City-based group.

Ifoghas Investments, an investment group linked to the Safra family, famed for a global banking dynasty, has invested in Amyl Therapeutics, a biotech group. Ifoghas was among seven investors committing €8.6 million to the Belgium-based group. 

Series C 

L Catterton, the private equity group owned by the Arnault family, has invested in Hungryroot, an e-commerce group. L Catterton committed $40 million to the New York City-based group.  

Subscribe

You will need a Premium Plus Subscription to access this database.

Exclusive news, analysis and research on global family enterprise and private investment offices.

Access to the most comprehensive fully interactive database on global family offices, principal investment offices, and family enterprises.

Check Deal Data, Senior Staff, and New Analysis on more than 500 family/principal investment and holding groups

Already have an account? Login

Subscribe

You need at least a Premium Subscription to read this article.

The most comprehensive information service on the global family enterprise world, featuring exclusive news, analysis, research and data on global family enterprises, family offices, and private investment offices.

Premium

£299

per year

  • Exclusive reports, analysis and commentary
  • Exclusive access to family/private investment office deal information
  • Exclusive interviews with principals and senior management of family/investment offices
SUBSCRIBE NOW

Premium+

£399

per year

  • Access to All of Premium
  • Access to all of FamilyCapital Analytics, our interactive database with more than 500 detailed profiles of family investment groups

More Info

SUBSCRIBE NOW

Already have an account? Login

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

Membership

Free

  • Exclusive reports, analysis and commentary
REGISTER NOW

Premium

£299

per year

  • Exclusive reports, analysis and commentary
  • Exclusive access to family/private investment office deal information
  • Exclusive interviews with principals and senior management of family/investment offices
SUBSCRIBE NOW

Premium+

£399

per year

  • Access to All of Premium
  • Access to all of FamilyCapital Analytics, our interactive database with more than 500 detailed profiles of family investment groups

More Info

SUBSCRIBE NOW

Already have an account? Login

Leave a Reply